Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Prostaglandin E2 (PGE2) exerts its effects via four E-prostanoid (EP) receptors (EP1-EP4).
• The in vivo functions of individual EP receptor subtypes, particularly EP3, remain largely uncharacterized.
• EP3 receptors are highly expressed in the kidney, suggesting a role in renal function.

Purpose of the Study:

• To investigate the in vivo role of the EP3 receptor in regulating urinary concentrating mechanisms.
• To determine if EP3 receptor deficiency affects kidney function and response to vasopressin.
• To elucidate the specific contribution of EP3 to PGE2-mediated renal effects.

Main Methods:

• Generation of EP3-deficient (-/-) mice using gene targeting.
• Assessment of urinary concentrating ability in EP3 -/- and wild-type (EP3 +/+) mice.
• Inhibition of endogenous PGE2 production using indomethacin.

Main Results:

• EP3 -/- mice exhibited normal survival, reproduction, and organ system development.
• Basal urine osmolality was comparable between EP3 -/- and wild-type mice.
• EP3 -/- mice showed impaired urine osmolality increase upon indomethacin treatment, unlike wild-type mice.
• Despite this, EP3 -/- mice maintained normal urine concentration and dilution responses to physiological stimuli.

Conclusions:

• PGE2, acting through the EP3 receptor, modulates kidney concentrating mechanisms.
• The EP3 receptor's role in modulating urinary osmolality is not essential for normal physiological regulation.
• These findings highlight a specific, yet non-critical, function of the EP3 receptor in renal physiology.